These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28024648)

  • 1. Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy.
    Samson P; Puri V; Broderick S; Patterson GA; Meyers B; Crabtree T
    Ann Thorac Surg; 2017 Feb; 103(2):406-415. PubMed ID: 28024648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of lymph node removal during esophageal cancer surgery and survival.
    van der Schaaf M; Johar A; Wijnhoven B; Lagergren P; Lagergren J
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25748792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
    Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
    Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
    Phillips AW; Lagarde SM; Navidi M; Disep B; Griffin SM
    Ann Surg; 2017 Apr; 265(4):750-756. PubMed ID: 27467444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node ratio is a significant predictor of disease-specific mortality in patients undergoing esophagectomy for cancer.
    Fox M; Farmer R; Scoggins CR; McMasters KM; Martin RC
    Am Surg; 2012 May; 78(5):528-34. PubMed ID: 22546123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
    Mariette C; Piessen G; Briez N; Triboulet JP
    Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study.
    Semenkovich TR; Subramanian M; Yan Y; Hofstetter WL; Correa AM; Cassivi SD; Inra ML; Stiles BM; Altorki NK; Chang AC; Brescia AA; Darling GE; Allison F; Broderick SR; Etchill EW; Fernandez FG; Chihara RK; Litle VR; Muñoz-Largacha JA; Kozower BD; Puri V; Meyers BF
    Ann Thorac Surg; 2019 Sep; 108(3):828-836. PubMed ID: 31229485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for patients with pathologic node-positive esophageal cancer after induction chemotherapy is associated with improved survival.
    Samson P; Puri V; Lockhart AC; Robinson C; Broderick S; Patterson GA; Meyers B; Crabtree T
    J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1725-1735. PubMed ID: 30054137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer.
    Cao J; Yuan P; Ma H; Ye P; Wang Y; Yuan X; Bao F; Lv W; Hu J
    Ann Thorac Surg; 2016 Aug; 102(2):424-32. PubMed ID: 27180928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Feasibility and safety of radical mediastinal lymphadenectomy in thoracoscopic esophagectomy for esophageal cancer].
    Zhang Y; Tan LJ; Feng MX; Wang H; Wang Q
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):855-9. PubMed ID: 23291137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial.
    Li B; Hu H; Zhang Y; Zhang J; Miao L; Ma L; Luo X; Zhang Y; Ye T; Li H; Zhou J; Li Y; Shen L; Zhao K; Fan M; Zhu Z; Wang J; Xu J; Deng Y; Lu Q; Jia H; Cheng X; Li H; Zhang Y; Li C; Pan Y; Liu S; Hu H; Shao L; Sun Y; Xiang J; Chen H
    Ann Surg; 2018 May; 267(5):826-832. PubMed ID: 28448385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients.
    Wang Y; Zhang X; Zhang X; Liu-Helmersson J; Zhang L; Xiao W; Jiang Y; Liu K; Sang S
    BMC Cancer; 2021 Apr; 21(1):403. PubMed ID: 33853577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Impact of Total Resected Lymph Nodes in Esophageal Cancer Patients With and Without Neoadjuvant Chemoradiation.
    Ho HJ; Chen HS; Hung WH; Hsu PK; Wu SC; Chen HC; Wang BY
    Ann Surg Oncol; 2018 Dec; 25(13):3820-3832. PubMed ID: 30284131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
    Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
    Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Multicenter Study on the Impact of Extracapsular Lymph Node Involvement in Primary Surgery Adenocarcinoma of the Esophagus on Overall Survival and Staging Systems.
    Nafteux PR; Lerut AM; Moons J; Hölscher AH; Bollschweiler E; van Berge Henegouwen MI; Lagarde SM; van Lanschot JJ; Messager M; Mariette C; D'Journo XB; Thomas PA; De Leyn PR
    Ann Surg; 2015 Nov; 262(5):809-15; discussion 815-6. PubMed ID: 26583670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer.
    Samson P; Puri V; Broderick S; Patterson GA; Meyers B; Crabtree T
    Ann Thorac Surg; 2017 Apr; 103(4):1101-1108. PubMed ID: 28109569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited Lymph Node Resection Does Not Decrease Postoperative Mortality After Esophagectomy in Octogenarians With Thoracic Esophageal Cancer.
    Li Q; Zhu S; Liu S; Zhang G; Li X
    J Surg Res; 2021 Mar; 259():538-545. PubMed ID: 33162102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher lymph node harvest in patients with a pathologic complete response after neoadjuvant therapy for esophageal cancer is associated with improved survival.
    Lutfi W; Martinez-Meehan D; Dhupar R; Christie N; Sarkaria I; Ekeke C; Baker N; Luketich JD; Okusanya OT
    J Surg Oncol; 2020 Mar; 121(4):654-661. PubMed ID: 31970776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy.
    Nigro JJ; DeMeester SR; Hagen JA; DeMeester TR; Peters JH; Kiyabu M; Campos GM; Oberg S; Gastal O; Crookes PF; Bremner CG
    J Thorac Cardiovasc Surg; 1999 May; 117(5):960-8. PubMed ID: 10220691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
    Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.